*** ONE-TIME USE *** A sign is posted at the Johnson & Johnson campus in Irvine, California.
Mario Tama/Getty Images
It’s crunchtime for investors in
Johnson & Johnson
who need to make a decision soon about whether to participate in J&J’s $40 billion exchange offer for shares in
Kenvue
the consumer health business that J&J took public in May,
